Opiant Pharmaceuticals, Inc.
OPNT · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,009 | -$1,861 | $11,593 | -$21,195 |
| Dep. & Amort. | $662 | $608 | $238 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,748 | $2,279 | $3,197 | $0 |
| Change in WC | -$4,760 | -$3,072 | -$10,948 | $14,127 |
| Other Non-Cash | $268 | $16 | -$17 | $782 |
| Operating Cash Flow | $1,926 | -$2,029 | $4,064 | -$523 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$51 | -$302 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15,015 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$15,015 | -$51 | -$302 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $20 | $0 | $0 | $17,153 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,718,940 | $19,369 | $2,605 | $17,021 |
| Financing Cash Flow | $2,719 | $19,369 | $2,605 | $17,021 |
| Forex Effect | -$28 | -$19 | $0 | $0 |
| Net Chg. in Cash | -$10,397 | $17,271 | $6,367 | $16,498 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $48,251 | $30,980 | $24,614 | $8,116 |
| End Cash | $37,854 | $48,251 | $30,980 | $24,614 |
| Free Cash Flow | $1,926 | -$2,080 | $3,761 | -$523 |